A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy (HOPE-3)
Muscular Dystrophies Muscular Dystrophy, Duchenne Muscular Disorders, Atrophic Muscular Diseases Neuromuscular Diseases Genetic Diseases, X-Linked Genetic Diseases, Inborn Nervous System Diseases Duchenne Muscular Dystrophy Cell Therapy Performance of the Upper Limb Ambulatory Non-Ambulatory CAP-1002
Lead Scientist at University of California Health
- Craig McDonald, MD (ucdavis)
Professor, Physical Medicine and Rehabilitation. Authored (or co-authored) 205 research publications.
- not yet accepting patients
- Start Date
- Completion Date
- Capricor Inc.
- Phase 3
- Study Type
- Last Updated